- Report
- October 2021
- 202 Pages
Global
From €3055EUR$3,185USD£2,625GBP
€4365EUR$4,550USD£3,750GBP
- Report
- June 2019
- 115 Pages
Global
From €4269EUR$4,450USD£3,667GBP
- Report
- April 2023
- 94 Pages
North America
From €1439EUR$1,500USD£1,236GBP
- Report
- June 2022
- 300 Pages
Global
From €3453EUR$3,600USD£2,967GBP
- Report
- October 2023
- 93 Pages
Global
From €3500EUR$3,908USD£3,112GBP
- Report
- July 2022
- 132 Pages
Global
From €815EUR$850USD£700GBP
- Report
- April 2024
- 132 Pages
Global
From €911EUR$950USD£783GBP
- Report
- May 2022
- 270 Pages
Global
From €3425EUR$3,570USD£2,942GBP
- Report
- September 2021
- 214 Pages
Global
From €3561EUR$3,712USD£3,059GBP
Plasma Therapy is a form of biopharmaceutical treatment that involves the use of plasma from a donor to treat a variety of medical conditions. Plasma is the liquid component of blood that contains proteins, antibodies, and other substances that can be used to treat a variety of diseases. Plasma Therapy is used to treat conditions such as hemophilia, immune deficiencies, and other autoimmune diseases. It is also used to treat certain types of cancer, as well as to reduce the risk of infection in patients with weakened immune systems.
Plasma Therapy is a relatively new form of biopharmaceutical treatment, and its use is increasing as more research is conducted into its potential benefits. It is a safe and effective form of treatment, and is often used in combination with other treatments to maximize its effectiveness.
Some companies in the Plasma Therapy market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more
